Fate Therapeutics Showcases Clinical Data for FT836 at the American Society of Cancer Oncology Annual Meeting
Go back to Fate Therapeutics Showcases Clinical Data for FT836 at the American Society of Cancer Oncology Annual Meeting| FATE THERAPEUTICS (NASDAQ: FATE) | Delayed: 2.15 +0.06 (2.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.09 | 52 Week High | $4.76 | |||
| Open | $2.07 | 52 Week Low | $1.46 | |||
| Day High | $2.23 | P/E | N/A | |||
| Day Low | $2.01 | EPS | $-1.91 | |||
| Volume | 5,698,136 | |||||
